Search

Skip to main content Lab Fun 2025 Lab member at the Katy Trail Ice House

Join the Hancks Lab team

The Tu Lab applies an integrative approach that combines stem cells, tissue engineering, molecular biology, and multiomics technologies to study acquired and genetic cardiac disorders, with the ultimate goal of developing precision medicine for heart disease. 

Meet the Radhakrishnan Lab team.

Skip to main content Disparities in Cirrhosis and HCC Outcomes We have highlighted notable disparities in access to care and outcomes among patients with chronic liver disease and/or HCC across racial, ethnic, and socioeconomic groups. We have shown that several social determinants of health signific…

Skip to main content Variation in HCC tumor growth patterns and prognosis Understanding tumor biology and growth patterns is essential for prognostication in HCC. Although HCC is associated with high mortality overall, we have shown there is significant heterogeneity in tumor doubling times and progr…

Skip to main content Guidelines and Expert Consensus Statements We have helped shape clinical practice through guidelines, white papers, and expert consensus statements. These publications provide frameworks for biomarker development, risk stratification, and treatment recommendations. They also high…

The Kuriki Lab advances AI that improves radiology workflows and outcomes. We serve as a hub for development, validation, deployment, and post-market monitoring of AI tools—improving efficiency for administrators, radiologists, and referring physicians, and ultimately improving patient outcomes. We also evaluate ROI and detect failure modes to guide safe, sustainable adoption.

Opportunities to join the Tambar Lab.

Learn about the Radhakrishnan Lab research.